UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:August 18,
CytomX Therapeutics (NASDAQ:CTMX)
Gráfica de Acción Histórica
De Ago 2024 a Sep 2024 Haga Click aquí para más Gráficas CytomX Therapeutics.
CytomX Therapeutics (NASDAQ:CTMX)
Gráfica de Acción Histórica
De Sep 2023 a Sep 2024 Haga Click aquí para más Gráficas CytomX Therapeutics.

Noticias sobre Cytomx Therapeutics, Inc. CTMX

CytomX Therapeutics Announces First Patient Dosed with CX-801, a Dually-Masked Interferon-Alpha 2b PROBODY®, in a Phase 1 Study in Patients with Solid Tumors
Lunes 9 de Septiembre 2024 (1 semana hace) • GlobeNewswire Inc.
CytomX Therapeutics to Present at Upcoming September Investor Conferences
Miércoles 4 de Septiembre 2024 (2 semanas hace) • GlobeNewswire Inc.
Form 4 - Statement of changes in beneficial ownership of securities
Jueves 22 de Agosto 2024 (4 semanas hace) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Jueves 22 de Agosto 2024 (4 semanas hace) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Jueves 22 de Agosto 2024 (4 semanas hace) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Jueves 22 de Agosto 2024 (4 semanas hace) • Edgar (US Regulatory)
Form EFFECT - Notice of Effectiveness
Lunes 19 de Agosto 2024 (4 semanas hace) • Edgar (US Regulatory)
Form S-3 - Registration statement under Securities Act of 1933
Viernes 9 de Agosto 2024 (1 mes hace) • Edgar (US Regulatory)
CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
Jueves 8 de Agosto 2024 (1 mes hace) • GlobeNewswire Inc.
Form 8-K - Current report
Jueves 8 de Agosto 2024 (1 mes hace) • Edgar (US Regulatory)
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jueves 8 de Agosto 2024 (1 mes hace) • Edgar (US Regulatory)
CytomX Therapeutics to Report Second Quarter 2024 Financial Results on August 8, 2024
Jueves 1 de Agosto 2024 (2 meses hace) • GlobeNewswire Inc.

Más de Cytomx Therapeutics, Inc. Artículos de Noticias